Investor directory

Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that discovers, develops, manufactures, and markets medicines across neuroscience, cardiometabolic, cancer, and immunology. It operates manufacturing and distribution facilities in the United States, Puerto Rico, and 25 other countries, with products sold in about 135 countries. Its portfolio includes Verzenio for cancer; Mounjaro and Zepbound for cardiometabolic indications; Jardiance and Trulicity; Humalog and Humulin for diabetes; and Taltz and Olumiant for immunology.
http://www.lilly.com
https://app.dealroom.co/companies/eli_lilly_and_company
https://crunchbase.com/organization/eli-lilly
https://linkedin.com/company/1663
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=285467
https://www.privateequityinternational.com/database/#/profile?id=160

Andrew Adams

Group Vice President - Molecule Discovery and Director, Lilly Institutes of Genetic Medicine

Anat Ashkenazi

CFO

Gordon Brooks

Group Vice President - Controller and Corporate Strategy

Ronald DeMattos

Senior Vice President and Chief Scientific Officer Neurobiologics

Lotus Mallbris Ph.D

Vice President of Development and Immunology

Teresa Millan

Corporate Affairs Director

Jacob Van Naarden

President

Diogo Rau

Executive Vice President and Chief Information and Digital Officer

Melissa Seymour

Executive VP of Global Quality

David Thompson

Chief Alliance Officer

Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.